Rein Therapeutics (RNTX) Share-based Compensation (2016 - 2026)
Rein Therapeutics (RNTX) reported Share-based Compensation of $164,000 for Q2 2026, down 35.9% from $256,000 a year earlier but up 5.1% from the prior quarter.
Powered by 
Analysis
Rein Therapeutics (RNTX) Share-based Compensation (2016 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Rein Therapeutics' Share-based Compensation came in at $2.02 million, up 74.3% year-over-year; for FY2025, it was $2.22 million, up 99.1% from FY2024.
- Share-based Compensation has a five-year compound annual growth rate of 3.3% (FY2020 to FY2025).
- By year, Share-based Compensation came in at $1.12 million in FY2024 (-6.1%), $1.19 million in FY2023 (-42.9%), $2.08 million in FY2022 (-7.8%) and $2.26 million in FY2021 (+19.4%).
- Five-year quarterly Share-based Compensation spans a low of $133,000 in Q4 2024 and a high of $1.45 million in Q3 2025.
- Year over year, Share-based Compensation gained in four of the last eight quarters, with growth averaging 40.9%.
- The high point for year-over-year Share-based Compensation in five years was Q3 2025 (growth of 184.8%); the low point was Q1 2024 (a decline of 61.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $156,000 (Q1 2026), $257,000 (Q4 2025) and $1.45 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Rein Therapeutics | 48.30 Mn | 48.30 Mn | - | 164,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 164,000.00 |
| Mar 31, 2026 | 156,000.00 |
| Dec 31, 2025 | 257,000.00 |
| Sep 30, 2025 | 1.45 Mn |
| Jun 30, 2025 | 256,000.00 |
| Mar 31, 2025 | 264,000.00 |
| Dec 31, 2024 | 133,000.00 |
| Sep 30, 2024 | 508,000.00 |
| Jun 30, 2024 | 326,000.00 |
| Mar 31, 2024 | 150,000.00 |
| Dec 31, 2023 | 270,000.00 |
| Sep 30, 2023 | 229,000.00 |
| Jun 30, 2023 | 300,000.00 |
| Mar 31, 2023 | 391,000.00 |
| Dec 31, 2022 | 424,000.00 |
| Sep 30, 2022 | 442,000.00 |
| Jun 30, 2022 | 528,000.00 |
| Mar 31, 2022 | 689,000.00 |
| Dec 31, 2021 | 607,000.00 |
| Sep 30, 2021 | 660,000.00 |
API Access
Rein Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=RNTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "RNTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=RNTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();